• Daylesford Capital provides capital for use by law firms in connection with mass tort claims involving toxic chemicals.

    About Daylesford Capital

     

    Daylesford Capital is a private investment company that specifically invests in mass tort cases believed to be high value and meritorious. We provide capital of up to $10 million to law firms to pay attorneys’ fees and expenses incurred in litigation. If the litigation is successful, Daylesford Capital is paid back its investment plus an agreed-upon return. If the litigation is unsuccessful, the law firm owes us nothing.

     

    We manage a diversified portfolio of legal claims, and consider investments in a variety of industries and market sectors in numerous jurisdictions exclusively classified as mass torts or single wrongful actions that causes injury to many different people. Our clients are leading law firms with significant contingency fee portfolios wishing to de-risk and monetize their investments.

     

    We invest in claims at all stages of the litigation life cycle, including during the initial dispute or pre-filing phase; before, during and after the completion of discovery and dispositive motions; through the pre-trial and trial process; and during appeal. Through non-recourse loan arrangements, plaintiffs’ attorneys receive financing in exchange for a percentage of any contingency fee award.